Elevate Uranium's Technical Advances Fail to Halt Share Price Slide

Elevate Uranium shares fall 9.3% to €0.14 despite 31% resource upgrade at Marenica; market awaits U-pgrade pilot plant results and uranium price recovery.

The market is delivering a harsh verdict on Elevate Uranium, even as the company posts impressive resource gains and pushes ahead with its proprietary processing technology. Shares tumbled to €0.14 on Tuesday, marking a 9.3% single-day decline that dragged the stock back to levels last seen in mid-August 2025. The sell-off extended a broader retreat that has now wiped out more than half the value from the 52-week high of €0.29.

Investors appear to be looking past the operational milestones. Elevate recently upgraded its mineral resource estimate for the Marenica project in Namibia to 52.8 million pounds of uranium oxide (U?O?) at a grade of 180 ppm. That represents a 31% increase since the start of the year, driven by infill drilling that added 12.6 million pounds. The deposit sits in the Erongo uranium district, one of the world's most significant uranium regions and home to several producing mines, where Elevate holds a 75% stake.

The resource boost brings the company's total Namibian inventory to 129 million pounds, and its global resource base to 173 million pounds – a substantial position for an explorer. Yet the stock continues to slide, now trading roughly 17% below its 50-day moving average and 23% beneath the 200-day line. The relative strength index sits at 43.7, indicating mild oversold conditions but no clear bottom.

What is missing, analysts note, is a conversion of geological promise into economic reality. The market is waiting for hard numbers from the pilot plant testing the company's patented U-pgrade™ process, which aims to slash processing costs by removing much of the waste rock before leaching. Independent estimates suggest the technology could cut milling and extraction expenses by up to half compared with conventional methods. Pilot operations in Namibia are currently running mass samples from the expanded Marenica area, and the results are expected to feed into forthcoming feasibility studies. Drill crews are also working to upgrade inferred resources to the indicated category, a prerequisite for detailed development planning.

Elevate Uranium's fate now hinges on two catalysts: successful validation of U-pgrade™ at a larger scale and a recovery in uranium prices, which have weighed on the entire exploration sector. Until either materialises, the company remains a high-risk proposition – one where technical progress on the ground has yet to translate into shareholder confidence.